Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender

F. Rota, M. C. Savanelli, L. Tauchmanova, S. Savastano, G. Lombardi, A. Colao, C. Di Somma

Research output: Contribution to journal › Article

16 Citations (Scopus)

Abstract

GH deficiency (GHD) in adults is accompanied by reduced bone mass that may revert only after 2 yr of GH replacement. However, it is unclear whether the gender may modify bone responsiveness to GH replacement in adults. In this study we have evaluated whether bone mineral density (BMD) and turnover improve after GH replacement according to patients' gender. BMD at lumbar spine (LS) and femoral neck (FN), serum osteocalcin (OC), and urinary cross-linked N-telopeptides of type I collagen (Ntx) were assessed in 64 hypopituitaric patients (35 men, 30-50 yr) before and 2 yr after the beginning of GH replacement. Values of IGF-I and BMD at LS and at FN were expressed as Z-scores. At study entry, IGF-I and BMD resulted similar among men and women with GHD. During GH replacement, IGF-1 levels increased in both men and women without any difference in the percentage of IGF-I increase between the genders (p=0.47). In women receiving estrogen replacement, however, the percentage of IGF-I increase (p

Original languageEnglish
Pages (from-to)94-103
Number of pages10
JournalJournal of Endocrinological Investigation
Volume31
Issue number2
Publication statusPublished - Feb 2008

Fingerprint

Bone Remodeling
Insulin-Like Growth Factor I
Bone Density
Growth Hormone
Young Adult
Femur Neck
Spine
Bone and Bones
Estrogen Replacement Therapy
Osteocalcin
Collagen Type I
Serum

Keywords

  • 1GF-I
  • BMD
  • Bone turnover
  • GH
  • GH deficiency
  • Osteocalcin
  • Osteopenia
  • Urinary Ntx

ASJC Scopus subject areas

  • Endocrinology

Cite this

Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender. / Rota, F.; Savanelli, M. C.; Tauchmanova, L.; Savastano, S.; Lombardi, G.; Colao, A.; Di Somma, C.

In: Journal of Endocrinological Investigation, Vol. 31, No. 2, 02.2008, p. 94-103.

Research output: Contribution to journal › Article

Rota, F, Savanelli, MC, Tauchmanova, L, Savastano, S, Lombardi, G, Colao, A & Di Somma, C 2008, 'Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender', Journal of Endocrinological Investigation, vol. 31, no. 2, pp. 94-103.
Rota F, Savanelli MC, Tauchmanova L, Savastano S, Lombardi G, Colao A et al. Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender. Journal of Endocrinological Investigation. 2008 Feb;31(2):94-103.
Rota, F. ; Savanelli, M. C. ; Tauchmanova, L. ; Savastano, S. ; Lombardi, G. ; Colao, A. ; Di Somma, C. / Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender. In: Journal of Endocrinological Investigation. 2008 ; Vol. 31, No. 2. pp. 94-103.
@article{696edca3dab0457e99da25bd0cd34ba0,
title = "Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender",
abstract = "GH deficiency (GHD) in adults is accompanied by reduced bone mass that may revert only after 2 yr of GH replacement. However, it is unclear whether the gender may modify bone responsiveness to GH replacement in adults. In this study we have evaluated whether bone mineral density (BMD) and turnover improve after GH replacement according to patients' gender. BMD at lumbar spine (LS) and femoral neck (FN), serum osteocalcin (OC), and urinary cross-linked N-telopeptides of type I collagen (Ntx) were assessed in 64 hypopituitaric patients (35 men, 30-50 yr) before and 2 yr after the beginning of GH replacement. Values of IGF-I and BMD at LS and at FN were expressed as Z-scores. At study entry, IGF-I and BMD resulted similar among men and women with GHD. During GH replacement, IGF-1 levels increased in both men and women without any difference in the percentage of IGF-I increase between the genders (p=0.47). In women receiving estrogen replacement, however, the percentage of IGF-I increase (p",
keywords = "1GF-I, BMD, Bone turnover, GH, GH deficiency, Osteocalcin, Osteopenia, Urinary Ntx",
author = "F. Rota and Savanelli, {M. C.} and L. Tauchmanova and S. Savastano and G. Lombardi and A. Colao and {Di Somma}, C.",
year = "2008",
month = "2",
language = "English",
volume = "31",
pages = "94--103",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "2",

}

TY - JOUR

T1 - Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender

AU - Rota, F.

AU - Savanelli, M. C.

AU - Tauchmanova, L.

AU - Savastano, S.

AU - Lombardi, G.

AU - Colao, A.

AU - Di Somma, C.

PY - 2008/2

Y1 - 2008/2

N2 - GH deficiency (GHD) in adults is accompanied by reduced bone mass that may revert only after 2 yr of GH replacement. However, it is unclear whether the gender may modify bone responsiveness to GH replacement in adults. In this study we have evaluated whether bone mineral density (BMD) and turnover improve after GH replacement according to patients' gender. BMD at lumbar spine (LS) and femoral neck (FN), serum osteocalcin (OC), and urinary cross-linked N-telopeptides of type I collagen (Ntx) were assessed in 64 hypopituitaric patients (35 men, 30-50 yr) before and 2 yr after the beginning of GH replacement. Values of IGF-I and BMD at LS and at FN were expressed as Z-scores. At study entry, IGF-I and BMD resulted similar among men and women with GHD. During GH replacement, IGF-1 levels increased in both men and women without any difference in the percentage of IGF-I increase between the genders (p=0.47). In women receiving estrogen replacement, however, the percentage of IGF-I increase (p

AB - GH deficiency (GHD) in adults is accompanied by reduced bone mass that may revert only after 2 yr of GH replacement. However, it is unclear whether the gender may modify bone responsiveness to GH replacement in adults. In this study we have evaluated whether bone mineral density (BMD) and turnover improve after GH replacement according to patients' gender. BMD at lumbar spine (LS) and femoral neck (FN), serum osteocalcin (OC), and urinary cross-linked N-telopeptides of type I collagen (Ntx) were assessed in 64 hypopituitaric patients (35 men, 30-50 yr) before and 2 yr after the beginning of GH replacement. Values of IGF-I and BMD at LS and at FN were expressed as Z-scores. At study entry, IGF-I and BMD resulted similar among men and women with GHD. During GH replacement, IGF-1 levels increased in both men and women without any difference in the percentage of IGF-I increase between the genders (p=0.47). In women receiving estrogen replacement, however, the percentage of IGF-I increase (p

KW - 1GF-I

KW - BMD

KW - Bone turnover

KW - GH

KW - GH deficiency

KW - Osteocalcin

KW - Osteopenia

KW - Urinary Ntx

UR - http://www.scopus.com/inward/record.url?scp=42649103615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42649103615&partnerID=8YFLogxK

M3 - Article

C2 - 18362499

AN - SCOPUS:42649103615

VL - 31

SP - 94

EP - 103

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 2

ER -

Access to Document